Mucosal delivery of nanovaccine strategy against COVID-19 and its variants
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Junwoo | - |
dc.contributor.author | Khang, Dongwoo | - |
dc.date.accessioned | 2023-08-24T02:40:26Z | - |
dc.date.available | 2023-08-24T02:40:26Z | - |
dc.date.created | 2023-07-23 | - |
dc.date.issued | 2023-07 | - |
dc.identifier.issn | 2211-3835 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/88822 | - |
dc.description.abstract | Despite the global administration of approved COVID-19 vaccines (e.g., ChAdOx1 nCoV-19®, mRNA-1273®, BNT162b2®), the number of infections and fatalities continue to rise at an alarming rate because of the new variants such as Omicron and its subvariants. Including COVID-19 vaccines that are licensed for human use, most of the vaccines that are currently in clinical trials are administered via parenteral route. However, it has been proven that the parenteral vaccines do not induce localized immunity in the upper respiratory mucosal surface, and administration of the currently approved vaccines does not necessarily lead to sterilizing immunity. This further supports the necessity of a mucosal vaccine that blocks the main entrance route of COVID-19: nasal and oral mucosal surfaces. Understanding the mechanism of immune regulation of M cells and dendritic cells and targeting them can be another promising approach for the successful stimulation of the mucosal immune system. This paper reviews the basic mechanisms of the mucosal immunity elicited by mucosal vaccines and summarizes the practical aspects and challenges of nanotechnology-based vaccine platform development, as well as ligand hybrid nanoparticles as potentially effective target delivery agents for mucosal vaccines. © 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Chinese Academy of Medical Sciences | - |
dc.relation.isPartOf | Acta Pharmaceutica Sinica B | - |
dc.title | Mucosal delivery of nanovaccine strategy against COVID-19 and its variants | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 001045155500001 | - |
dc.identifier.doi | 10.1016/j.apsb.2022.11.022 | - |
dc.identifier.bibliographicCitation | Acta Pharmaceutica Sinica B, v.13, no.7, pp.2897 - 2925 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85147937079 | - |
dc.citation.endPage | 2925 | - |
dc.citation.startPage | 2897 | - |
dc.citation.title | Acta Pharmaceutica Sinica B | - |
dc.citation.volume | 13 | - |
dc.citation.number | 7 | - |
dc.contributor.affiliatedAuthor | Lee, Junwoo | - |
dc.contributor.affiliatedAuthor | Khang, Dongwoo | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | Dendritic cell (DC) | - |
dc.subject.keywordAuthor | Liposome | - |
dc.subject.keywordAuthor | Microfold cell (M cell) | - |
dc.subject.keywordAuthor | Mucosa-associated lymphoid tissue (MALT) | - |
dc.subject.keywordAuthor | Mucosal vaccine | - |
dc.subject.keywordAuthor | Polymeric nanoparticle | - |
dc.subject.keywordAuthor | Vaccine platforms | - |
dc.subject.keywordPlus | CD103(+) DENDRITIC CELLS | - |
dc.subject.keywordPlus | INTESTINAL M-CELLS | - |
dc.subject.keywordPlus | N-TRIMETHYL CHITOSAN | - |
dc.subject.keywordPlus | REGULATORY T-CELLS | - |
dc.subject.keywordPlus | INTRANASAL IMMUNIZATION | - |
dc.subject.keywordPlus | ENHANCED PROTECTION | - |
dc.subject.keywordPlus | ADHESION MOLECULES | - |
dc.subject.keywordPlus | PLGA NANOPARTICLES | - |
dc.subject.keywordPlus | ORAL IMMUNIZATION | - |
dc.subject.keywordPlus | VACCINE ADJUVANTS | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.